Preface
Part I General Aspects
1. Self-Experiments with Psychoactive Substances: A Historical Perspective
2. Responding to New Psychoactive Substances in the European Union: Early Warning, Risk Assessment, and Control Measures
3. Emergence, Diversity, and Control of New Psychoactive Substances: A Global Perspective
4. Epidemiology of NPS Based Confirmed Overdose Cases: The STRIDA Project
Part II Drug Classes
5. Neuropharmacology of Synthetic Cathinones
6. Pharmacology of MDMA- and Amphetamine-Like New Psychoactive Substances
7. The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonists as New Psychoactive Substances: Origins
8. Molecular pharmacology of synthetic cannabinoids: Evolution
9. Synthetic Opioids
10. Designer Benzodiazepines: Another Class of New Psychoactive Substances
11. Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action
12. 1,2-Diarylethylamine- and Ketamine-Based New Psychoactive Substances
13. Phencyclidine-Based New Psychoactive Substances
Part III Clinical, Forensic, and Analytical Toxicology
14. Bioanalytical Methods for New Psychoactive Substances
15. Wastewater Analysis for Community-Wide Drugs Use Assessment
16. Toxicokinetics of NPS: Update 2017
17. Patterns of Acute Toxicity Associated with New Psychoactive Substances
18. Fatal Poisonings Associated with New Psychoactive Substances.